Effect of oxiracetam on cerebral cholinergic imbalance secondary to an NMDA-receptor blockade.
Ponzio
F
F
ISF Laboratories for Biomedical Research, Milan, Italy.
Belfiore
P
P
Dorigotti
L
L
D015763:2-Amino-5-phosphonovalerate / Q000031:analogs & derivatives*; D000109:Acetylcholine / Q000378:metabolism; D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D007276:Injections, Intraventricular; D008297:Male; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000378:metabolism*
D000596:Amino Acids; D011759:Pyrrolidines; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D015763:2-Amino-5-phosphonovalerate; D000109:Acetylcholine; C031231:2-amino-7-phosphonoheptanoic acid; C040619:oxiracetam